This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Immudyne Appoints Karen Kingston, Former Brand Strategist For Johnson & Johnson, Pfizer, And Allergan, To Lead Global Marketing And Sales

NEW YORK, March 25, 2013 (GLOBE NEWSWIRE) -- Immudyne, Inc. (OTCQB:IMMD) announced today that Karen Kingston has been appointed as the company's Chief Marketing Officer to lead its global sales and marketing efforts.

Ms. Kingston has 15 years of experience successfully building brands and sales strategies within the men's health, eye care, skin care, immunology, and wellness industries. Most recently Ms. Kingston served as President & CEO of Varitage. Founded in 2007, Ms. Kingston leveraged her marketing expertise and technical knowledge to quickly secure Fortune 500 clients, including Johnson & Johnson, Medtronic, and Pfizer. Ms. Kingston also secured numerous medical device clients throughout the west coast, including OASIS Medical, Revision Optics, and Lumenis. Ms. Kingston has a stellar track record of transforming stagnant product portfolios into highly visible brands with accelerated revenue growth.

Prior to Varitage, Ms. Kingston spent more than 10 years working in sales and marketing for Pfizer, Allergan, and medical advertising agencies. She played a key role in marketing Viagra and was integral to shifting the brand focus to younger men and overall wellness.

"We are seeing increasing market demand for our Yeast Beta Glucan product line," said Mark McLaughlin, President & CEO of Immudyne. "Karen's know-how and proven ability to properly position and grow medical and wellness brands will be invaluable to us as we introduce new product lines from Immudyne's global portfolio."

As Chief Marketing Officer,  Ms. Kingston will spearhead the launch of several new product lines based upon Immudyne's proprietary and patented Yeast Beta Glucan.  She will also be responsible for the continued growth and management of Immudyne's sales and marketing team as well as the company's R&D of new product development initiatives.

"I believe there is tremendous opportunity to educate consumers on how critical the immune system is to overall health. Many adults are unaware that by taking simple actions to support their immune system, they can feel better, look better, and live healthier lives," said Ms. Kingston. "I am thrilled to have the opportunity to lead the marketing and sales efforts at Immudyne. Our products offer unique and meaningful benefits for both men and women and will help improve many, many lives."

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs